Prof. Katarzyna Kolasa
Department of Health Economics and Healthcare Management
Associate Professor
Publikacje w czasopismach naukowych:
KOLASA K., Mazzi F., Leszczuk-Czubkowska E., Zrubka Z., Péntek M. (2021), "State of the Art in Adoption of Contact Tracing Apps and Recommendations Regarding Privacy Protection and Public Health: Systematic Review", JMIR mHealth and uHealth, Vol 9, No 6, s. online, afiliacja: ALK.
KOLASA K., Goettsch W., Petrova G., Berler A. (2021), "Without data, you’re just another person with an opinion", EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, vol. 20, issue 2, s. 147-154, afiliacja: ALK.
Lichtenberg M., Stahlhoff S., Młyńczak K., Golicki D., Gagne P., Razavi M., de Graaf R., Kolluri R., KOLASA K. (2020), "Endovascular mechanical thrombectomy versus thrombolysis in patients with iliofemoral deep vein thrombosis - A systematic review and meta-analysis", Vasa-European Journal of Vascular Medicine, online, s. online, afiliacja: ALK.
KOLASA K., Kozinski G. (2020), "How to Value Digital Health Interventions? A Systematic Literature Review", INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, online, s. online, afiliacja: ALK.
Migliara B., Cappellari T., Mirandola M., Griso A., KOLASA K., Zah V., Nicoletti C., Lino M. (2020), "Treatment of bypass failure in patients with chronic limb threatening ischemia – open surgery vs. percutaneous mechanical thrombectomy", Vasa-European Journal of Vascular Medicine, online, s. online, afiliacja: ALK.
KOLASA K., Redekop W., Berler A., Zah V., Asche C. (2020), "Future of Data Analytics in the Era of the General Data Protection Regulation in Europe", PHARMACOECONOMICS, 38, s. 1021–1029, afiliacja: ALK.
KOLASA K., Zwolinski K., Zah V., Kaló Z., Lewandowski T. (2018), "Revealed preferences towards the appraisal of orphan drugs in Poland - multi criteria decision analysis", ORPHANET JOURNAL OF RARE DISEASES, online, s. 1-14, afiliacja: ALK.
KOLASA K., Kowalczyk M. (2017), "The effects of payments for pharmaceuticals: a systematic literature review", HEALTH ECONOMICS POLICY AND LAW, online, s. 1-18, afiliacja: Inna.
KOLASA K., Kowalczyk M. (2016), "Does cost sharing do more harm or more good? - a systematic literature review", BMC PUBLIC HEALTH, 16, s. 1-14, afiliacja: Inna.
KOLASA K., Zwolinski K., Hermanowski T. (2016), "Potential impact of the implementation of multiple-criteria decision analysis (MCDA) on the Polish pricing and reimbursement process of orphan drugs", ORPHANET JOURNAL OF RARE DISEASES, 11, s. 1-12, afiliacja: Inna.
KOLASA K., Kaló Z., Zah V. (2016), "The use of non-economic criteria in pricing and reimbursement decisions in Central and Eastern Europe: issues, trends and recommendations", EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 16(4), s. 483-488, afiliacja: Inna.
Hermanowski T., KOLASA K., Zawada A., Rybnik T., Rabczenko D., Cegłowska U. (2015), "Nierówność w dostępie do świadczeń zdrowotnych w Polsce w porównaniu z Danią i Niemcami. Analiza na podstawie danych z badania SHARE", POLITYKA SPOŁECZNA, 42, 2(491), s. 22-27, afiliacja: Inna.
KOLASA K., Kaló Z., Hornby E. (2015), "Pricing and reimbursement frameworks in Central Eastern Europe: a decision tool to support choices", EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 15, 1, s. 145-155, afiliacja: Inna.
KOLASA K., Lewandowski T. (2015), "Does it matter whose opinion we seek regarding the allocation of healthcare resources? - a case study", BMC HEALTH SERVICES RESEARCH, 15, s. 1-10, afiliacja: Inna.
KOLASA K., Dohnalik J., Borek E., Siemiątkowski M., Ścibiorski C. (2014), "The paradox of public participation in the healthcare in Poland – What citizens want, and what they think", HEALTH POLICY, 118, 2, s. 159-165, afiliacja: Inna.
KOLASA K. (2014), "Are pricing and reimbursement decision-making criteria aligned with public preferences regarding allocation principles in the Polish healthcare sector?", EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 14(5), s. 751-762, afiliacja: Inna.
KOLASA K., Annemans L., Lees M. (2013), "Attitudes toward supplementary criteria in the reimbursement process in Poland", INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 29, 4, s. 443-449, afiliacja: Inna.
KOLASA K. (2013), "Obiektywność decyzji refundacyjnych - czy zawsze musi się opłacać?", PRZEGLĄD EPIDEMIOLOGICZNY, 67, s. 599-603, afiliacja: Inna.
KOLASA K. (2013), "How much is the cost of multiple sclerosis – systematic literature review", PRZEGLĄD EPIDEMIOLOGICZNY, 67, s. 75-85, afiliacja: Inna.
KOLASA K., Hermanowski T., Borek E. (2013), "Importance of public participation in decision-making process in healthcare system illustarted with an example of the development of american and polish scope of health benefit basket", PRZEGLĄD EPIDEMIOLOGICZNY, 67, s. 661-666, afiliacja: Inna.
KOLASA K. (2012), "Współpłacenie za zdrowie - za i przeciw", POLITYKA SPOŁECZNA, 39, 10(463), s. 19-21, afiliacja: Inna.
KOLASA K., Wasiak R. (2012), "Health technology assessment in poland and scotland: comparison of process and decisions", INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 28, 1, s. 70-76, afiliacja: Inna.
KOLASA K., Grzeszczak W., Czupryniak L., Sciborski C., Lomon I., McEwan P. (2012), "The cost-effectiveness of saxagliptin versus NPH insulin when used in combination with other oral antidiabetes agents in the treatment of type 2 diabetes mellitus in Poland", DIABETES TECHNOLOGY & THERAPEUTICS, 14(1), s. 65-73, afiliacja: Inna.
KOLASA K., Rybnik T. (2012), "Socjodemograficzne uwarunkowania nierówności dostępu do usług zdrowotnych w Polsce w 2011 roku na przykładzie diagnozy społecznej", PRZEGLĄD EPIDEMIOLOGICZNY, 66(4), s. 681-688, afiliacja: Inna.
KOLASA K., Dziomdziora M., Fajutrao L. (2011), "What aspects of the health technology assessment process recommended by international health technology assessment agencies received the most attention in Poland in 2008?", INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 27, 1, s. 84-94, afiliacja: Inna.
KOLASA K., Schubert S., Hermanowski T. (2011), "A review of Health Technology Assessment (HTA) recommendations for drug therapies issued between 2007 and 2009 and their impact on policymaking processes in Poland", HEALTH POLICY, 102(2-3), s. 145-151, afiliacja: Inna.
Gustavsson A., Brinck P., Bergvall N., KOLASA K., Wimo A., Winblad B., Jönsson L. (2011), "Predictors of costs of care in Alzheimer's disease: a multinational sample of 1222 patients", Alzheimers & Dementia, 7(3), s. 318-327, afiliacja: Inna.
KOLASA K., Lees M. (2011), "PHP53 Assessment of the Attitudes of the General Public Towards Supplementary Criteria to Be Used in P&R Decision Making Process in Poland", VALUE IN HEALTH, 14, 7, s. A342, afiliacja: Inna.
Monografie:
KOLASA K. (2012), "Optymalna alokacja zasobów w ochronie zdrowia", Wolters Kluwer Polska, Warszawa, afiliacja: Inna.